Modulation  ||| S:0 E:11 ||| NNP
of  ||| S:11 E:14 ||| IN
p53  ||| S:14 E:18 ||| NN
binding  ||| S:18 E:26 ||| VBG
to  ||| S:26 E:29 ||| TO
MDM2 ||| S:29 E:33 ||| CD
:  ||| S:33 E:35 ||| :
computational  ||| S:35 E:49 ||| JJ
studies  ||| S:49 E:57 ||| NNS
reveal  ||| S:57 E:64 ||| VBP
important  ||| S:64 E:74 ||| JJ
roles  ||| S:74 E:80 ||| NNS
of  ||| S:80 E:83 ||| IN
Tyr100  ||| S:83 E:90 ||| CD
The  ||| S:90 E:94 ||| DT
tumor  ||| S:94 E:100 ||| NN
suppressor  ||| S:100 E:111 ||| NN
protein  ||| S:111 E:119 ||| NN
p53  ||| S:119 E:123 ||| NN
is  ||| S:123 E:126 ||| VBZ
regulated  ||| S:126 E:136 ||| VBN
by  ||| S:136 E:139 ||| IN
the  ||| S:139 E:143 ||| DT
ubiquitin  ||| S:143 E:153 ||| JJ
ligase  ||| S:153 E:160 ||| JJ
MDM2  ||| S:160 E:165 ||| NN
which  ||| S:165 E:171 ||| WDT
down-regulates  ||| S:171 E:186 ||| JJ
p53 ||| S:186 E:189 ||| NN
.  ||| S:189 E:191 ||| .
In  ||| S:191 E:194 ||| IN
tumours  ||| S:194 E:202 ||| NN
with  ||| S:202 E:207 ||| IN
overexpressed  ||| S:207 E:221 ||| CD
MDM2 ||| S:221 E:225 ||| CD
,  ||| S:225 E:227 ||| ,
the  ||| S:227 E:231 ||| DT
p53-MDM2  ||| S:231 E:240 ||| CD
interaction  ||| S:240 E:252 ||| NNS
can  ||| S:252 E:256 ||| MD
be  ||| S:256 E:259 ||| VB
interrupted  ||| S:259 E:271 ||| VBN
by  ||| S:271 E:274 ||| IN
a  ||| S:274 E:276 ||| DT
peptide  ||| S:276 E:284 ||| NN
or  ||| S:284 E:287 ||| CC
small  ||| S:287 E:293 ||| JJ
molecule  ||| S:293 E:302 ||| NN
to  ||| S:302 E:305 ||| TO
stabilize  ||| S:305 E:315 ||| VB
p53  ||| S:315 E:319 ||| NN
as  ||| S:319 E:322 ||| IN
a  ||| S:322 E:324 ||| DT
therapeutic  ||| S:324 E:336 ||| JJ
strategy ||| S:336 E:344 ||| NN
.  ||| S:344 E:346 ||| .
Structural  ||| S:346 E:357 ||| JJ
and  ||| S:357 E:361 ||| CC
biochemical ||| S:361 E:372 ||| CD
/ ||| S:372 E:373 ||| CD
mutagenesis  ||| S:373 E:385 ||| CD
data  ||| S:385 E:390 ||| NNS
show  ||| S:390 E:395 ||| VBP
that  ||| S:395 E:400 ||| DT
p53  ||| S:400 E:404 ||| NN
has  ||| S:404 E:408 ||| VBZ
3  ||| S:408 E:410 ||| CD
hydrophobic  ||| S:410 E:422 ||| CD
residues  ||| S:422 E:431 ||| CD
F19 ||| S:431 E:434 ||| CD
,  ||| S:434 E:436 ||| ,
W23  ||| S:436 E:440 ||| NNP
and  ||| S:440 E:444 ||| CC
L26  ||| S:444 E:448 ||| CD
that  ||| S:448 E:453 ||| IN
embed  ||| S:453 E:459 ||| NN
into  ||| S:459 E:464 ||| IN
the  ||| S:464 E:468 ||| DT
ligand  ||| S:468 E:475 ||| JJ
binding  ||| S:475 E:483 ||| JJ
pocket  ||| S:483 E:490 ||| NN
of  ||| S:490 E:493 ||| IN
MDM2  ||| S:493 E:498 ||| NNP
which  ||| S:498 E:504 ||| WDT
is  ||| S:504 E:507 ||| VBZ
highly  ||| S:507 E:514 ||| RB
plastic  ||| S:514 E:522 ||| JJ
in  ||| S:522 E:525 ||| IN
nature  ||| S:525 E:532 ||| NN
and  ||| S:532 E:536 ||| CC
can  ||| S:536 E:540 ||| MD
modulate  ||| S:540 E:549 ||| VB
its  ||| S:549 E:553 ||| PRP$
size  ||| S:553 E:558 ||| NN
to  ||| S:558 E:561 ||| TO
accommodate  ||| S:561 E:573 ||| VB
a  ||| S:573 E:575 ||| DT
variety  ||| S:575 E:583 ||| NN
of  ||| S:583 E:586 ||| IN
ligands ||| S:586 E:593 ||| NN
.  ||| S:593 E:595 ||| .
This  ||| S:595 E:600 ||| DT
binding  ||| S:600 E:608 ||| JJ
pocket  ||| S:608 E:615 ||| NN
is  ||| S:615 E:618 ||| VBZ
primarily  ||| S:618 E:628 ||| RB
dependent  ||| S:628 E:638 ||| JJ
on  ||| S:638 E:641 ||| IN
the  ||| S:641 E:645 ||| DT
orientation  ||| S:645 E:657 ||| NN
of  ||| S:657 E:660 ||| IN
a  ||| S:660 E:662 ||| DT
particular  ||| S:662 E:673 ||| JJ
residue ||| S:673 E:680 ||| NN
,  ||| S:680 E:682 ||| ,
Y100 ||| S:682 E:686 ||| NNP
.  ||| S:686 E:688 ||| .
We  ||| S:688 E:691 ||| PRP
have  ||| S:691 E:696 ||| VBP
studied  ||| S:696 E:704 ||| VBN
the  ||| S:704 E:708 ||| DT
role  ||| S:708 E:713 ||| NN
of  ||| S:713 E:716 ||| IN
the  ||| S:716 E:720 ||| DT
dynamics  ||| S:720 E:729 ||| NNS
of  ||| S:729 E:732 ||| IN
Y100  ||| S:732 E:737 ||| CD
in  ||| S:737 E:740 ||| IN
p53  ||| S:740 E:744 ||| NN
recognition ||| S:744 E:755 ||| NN
.  ||| S:755 E:757 ||| .
Molecular  ||| S:757 E:767 ||| JJ
dynamics  ||| S:767 E:776 ||| NNS
simulations  ||| S:776 E:788 ||| JJ
show  ||| S:788 E:793 ||| NN
that  ||| S:793 E:798 ||| IN
the  ||| S:798 E:802 ||| DT
Y100  ||| S:802 E:807 ||| JJ
side  ||| S:807 E:812 ||| NN
chain  ||| S:812 E:818 ||| NN
can  ||| S:818 E:822 ||| MD
be  ||| S:822 E:825 ||| VB
in  ||| S:825 E:828 ||| IN
open  ||| S:828 E:833 ||| JJ
or  ||| S:833 E:836 ||| CC
closed  ||| S:836 E:843 ||| JJ
states  ||| S:843 E:850 ||| NNS
with  ||| S:850 E:855 ||| IN
only  ||| S:855 E:860 ||| RB
the  ||| S:860 E:864 ||| DT
former  ||| S:864 E:871 ||| JJ
enabling  ||| S:871 E:880 ||| VBG
complex  ||| S:880 E:888 ||| JJ
formation ||| S:888 E:897 ||| NN
.  ||| S:897 E:899 ||| .
When  ||| S:899 E:904 ||| WRB
both  ||| S:904 E:909 ||| DT
p53  ||| S:909 E:913 ||| NN
and  ||| S:913 E:917 ||| CC
MDM2  ||| S:917 E:922 ||| NNP
are  ||| S:922 E:926 ||| VBP
in  ||| S:926 E:929 ||| IN
near  ||| S:929 E:934 ||| JJ
native  ||| S:934 E:941 ||| JJ
conformations ||| S:941 E:954 ||| NN
,  ||| S:954 E:956 ||| ,
complex  ||| S:956 E:964 ||| JJ
formation  ||| S:964 E:974 ||| NN
is  ||| S:974 E:977 ||| VBZ
rapid  ||| S:977 E:983 ||| JJ
and  ||| S:983 E:987 ||| CC
is  ||| S:987 E:990 ||| VBZ
driven  ||| S:990 E:997 ||| VBN
by  ||| S:997 E:1000 ||| IN
the  ||| S:1000 E:1004 ||| DT
formation  ||| S:1004 E:1014 ||| NN
of  ||| S:1014 E:1017 ||| IN
a  ||| S:1017 E:1019 ||| DT
hydrogen  ||| S:1019 E:1028 ||| NN
bond  ||| S:1028 E:1033 ||| NN
between  ||| S:1033 E:1041 ||| IN
W23  ||| S:1041 E:1045 ||| CD
of  ||| S:1045 E:1048 ||| IN
p53  ||| S:1048 E:1052 ||| NN
and  ||| S:1052 E:1056 ||| CC
L54  ||| S:1056 E:1060 ||| CD
of  ||| S:1060 E:1063 ||| IN
MDM2  ||| S:1063 E:1068 ||| NNP
or  ||| S:1068 E:1071 ||| CC
by  ||| S:1071 E:1074 ||| IN
the  ||| S:1074 E:1078 ||| DT
embedding  ||| S:1078 E:1088 ||| NN
of  ||| S:1088 E:1091 ||| IN
F19  ||| S:1091 E:1095 ||| CD
of  ||| S:1095 E:1098 ||| IN
p53  ||| S:1098 E:1102 ||| NN
into  ||| S:1102 E:1107 ||| IN
MDM2 ||| S:1107 E:1111 ||| CD
.  ||| S:1111 E:1113 ||| .
The  ||| S:1113 E:1117 ||| DT
transition  ||| S:1117 E:1128 ||| NN
of  ||| S:1128 E:1131 ||| IN
Y100  ||| S:1131 E:1136 ||| CD
from  ||| S:1136 E:1141 ||| IN
closed  ||| S:1141 E:1148 ||| VBN
to  ||| S:1148 E:1151 ||| TO
open  ||| S:1151 E:1156 ||| VB
can  ||| S:1156 E:1160 ||| MD
increase  ||| S:1160 E:1169 ||| VB
the  ||| S:1169 E:1173 ||| DT
size  ||| S:1173 E:1178 ||| NN
of  ||| S:1178 E:1181 ||| IN
the  ||| S:1181 E:1185 ||| DT
binding  ||| S:1185 E:1193 ||| JJ
site ||| S:1193 E:1197 ||| NN
.  ||| S:1197 E:1199 ||| .
Interconversions  ||| S:1199 E:1216 ||| NNP
between  ||| S:1216 E:1224 ||| IN
these  ||| S:1224 E:1230 ||| DT
two  ||| S:1230 E:1234 ||| CD
states  ||| S:1234 E:1241 ||| NNS
can  ||| S:1241 E:1245 ||| MD
be  ||| S:1245 E:1248 ||| VB
induced  ||| S:1248 E:1256 ||| VBN
by  ||| S:1256 E:1259 ||| IN
the  ||| S:1259 E:1263 ||| DT
N-terminal  ||| S:1263 E:1274 ||| JJ
region  ||| S:1274 E:1281 ||| NN
of  ||| S:1281 E:1284 ||| IN
MDM2  ||| S:1284 E:1289 ||| NNP
or  ||| S:1289 E:1292 ||| CC
by  ||| S:1292 E:1295 ||| IN
the  ||| S:1295 E:1299 ||| DT
conformations  ||| S:1299 E:1313 ||| NN
of  ||| S:1313 E:1316 ||| IN
the  ||| S:1316 E:1320 ||| DT
p53  ||| S:1320 E:1324 ||| NN
peptides ||| S:1324 E:1332 ||| NN
.  ||| S:1332 E:1334 ||| .
Molecular  ||| S:1334 E:1344 ||| JJ
dynamics  ||| S:1344 E:1353 ||| JJ
simulations  ||| S:1353 E:1365 ||| NNS
have  ||| S:1365 E:1370 ||| VBP
revealed  ||| S:1370 E:1379 ||| VBN
how  ||| S:1379 E:1383 ||| WRB
the  ||| S:1383 E:1387 ||| DT
binding  ||| S:1387 E:1395 ||| NN
of  ||| S:1395 E:1398 ||| IN
p53  ||| S:1398 E:1402 ||| NN
to  ||| S:1402 E:1405 ||| TO
MDM2  ||| S:1405 E:1410 ||| NNP
is  ||| S:1410 E:1413 ||| VBZ
modulated  ||| S:1413 E:1423 ||| VBN
by  ||| S:1423 E:1426 ||| IN
the  ||| S:1426 E:1430 ||| DT
conformational  ||| S:1430 E:1445 ||| JJ
mobility  ||| S:1445 E:1454 ||| NN
of  ||| S:1454 E:1457 ||| IN
Y100  ||| S:1457 E:1462 ||| NNP
which  ||| S:1462 E:1468 ||| WDT
is  ||| S:1468 E:1471 ||| VBZ
the  ||| S:1471 E:1475 ||| DT
gatekeeper  ||| S:1475 E:1486 ||| JJ
residue  ||| S:1486 E:1494 ||| NN
in  ||| S:1494 E:1497 ||| IN
MDM2 ||| S:1497 E:1501 ||| CD
.  ||| S:1501 E:1503 ||| .
The  ||| S:1503 E:1507 ||| DT
mobility  ||| S:1507 E:1516 ||| NN
of  ||| S:1516 E:1519 ||| IN
this  ||| S:1519 E:1524 ||| DT
residue  ||| S:1524 E:1532 ||| NN
can  ||| S:1532 E:1536 ||| MD
be  ||| S:1536 E:1539 ||| VB
modulated  ||| S:1539 E:1549 ||| VBN
by  ||| S:1549 E:1552 ||| IN
the  ||| S:1552 E:1556 ||| DT
conformations  ||| S:1556 E:1570 ||| NN
of  ||| S:1570 E:1573 ||| IN
p53  ||| S:1573 E:1577 ||| NN
and  ||| S:1577 E:1581 ||| CC
the  ||| S:1581 E:1585 ||| DT
Nterminal  ||| S:1585 E:1595 ||| JJ
lid  ||| S:1595 E:1599 ||| NN
region  ||| S:1599 E:1606 ||| NN
of  ||| S:1606 E:1609 ||| IN
MDM2 ||| S:1609 E:1613 ||| CD
.  ||| S:1613 E:1615 ||| .
